Synopsys Balance Sheet Health
Financial Health criteria checks 6/6
Synopsys has a total shareholder equity of $6.7B and total debt of $17.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $10.6B and $3.9B respectively. Synopsys's EBIT is $1.4B making its interest coverage ratio -34.6. It has cash and short-term investments of $1.3B.
Key information
0.3%
Debt to equity ratio
US$16.95m
Debt
| Interest coverage ratio | -34.6x |
| Cash | US$1.27b |
| Equity | US$6.71b |
| Total liabilities | US$3.85b |
| Total assets | US$10.56b |
Recent financial health updates
Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet
Apr 02
We Think Synopsys (NASDAQ:SNPS) Can Manage Its Debt With Ease
Oct 12Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Jul 03Synopsys (NASDAQ:SNPS) Seems To Use Debt Rather Sparingly
Jan 22Recent updates
Is Now The Time To Put Synopsys (NASDAQ:SNPS) On Your Watchlist?
Apr 16Synopsys: Potential Further Upside For Compounding Machine
Apr 04Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet
Apr 02Synopsys: A Quality Compounder With A Stretched Valuation
Mar 25Synopsys (NASDAQ:SNPS) Might Have The Makings Of A Multi-Bagger
Mar 20Synopsys Q1 Earnings Preview: Why The ANSYS Acquisition May Destroy Shareholder Value
Feb 21With Synopsys, Inc. (NASDAQ:SNPS) It Looks Like You'll Get What You Pay For
Jan 23What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?
Jan 09Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors
Dec 28Charting the Course: Unlocking Potential in Tech
Dec 15
Charting the Course: Unlocking Potential in Tech
Dec 15Calculating The Intrinsic Value Of Synopsys, Inc. (NASDAQ:SNPS)
Dec 13There's Been No Shortage Of Growth Recently For Synopsys' (NASDAQ:SNPS) Returns On Capital
Oct 25We Think Synopsys (NASDAQ:SNPS) Can Manage Its Debt With Ease
Oct 12Is It Time To Consider Buying Synopsys, Inc. (NASDAQ:SNPS)?
Sep 29A Look At The Intrinsic Value Of Synopsys, Inc. (NASDAQ:SNPS)
Aug 16Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Jul 03Is It Time To Consider Buying Synopsys, Inc. (NASDAQ:SNPS)?
Jun 19Returns Are Gaining Momentum At Synopsys (NASDAQ:SNPS)
May 18Synopsys, Inc. (NASDAQ:SNPS) Shares Could Be 24% Above Their Intrinsic Value Estimate
Apr 19We Take A Look At Why Synopsys, Inc.'s (NASDAQ:SNPS) CEO Has Earned Their Pay Packet
Apr 06Why Synopsys, Inc. (NASDAQ:SNPS) Could Be Worth Watching
Mar 13Synopsys (NASDAQ:SNPS) Is Experiencing Growth In Returns On Capital
Feb 13Synopsys (NASDAQ:SNPS) Seems To Use Debt Rather Sparingly
Jan 22Calculating The Fair Value Of Synopsys, Inc. (NASDAQ:SNPS)
Jan 10Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors
Dec 19Financial Position Analysis
Short Term Liabilities: SNPS's short term assets ($3.4B) exceed its short term liabilities ($2.6B).
Long Term Liabilities: SNPS's short term assets ($3.4B) exceed its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: SNPS has more cash than its total debt.
Reducing Debt: SNPS's debt to equity ratio has reduced from 14.3% to 0.3% over the past 5 years.
Debt Coverage: SNPS's debt is well covered by operating cash flow (8853.4%).
Interest Coverage: SNPS earns more interest than it pays, so coverage of interest payments is not a concern.